IDKmonitor® Infliximab Total ADA ELISA
Sample Type (Matrix): Serum, EDTA Plasma
Sample Volume: 25 µl
Incubation time: 3h
Size: 96 wells
Regulatory Status: For research use only in the U.S. Health Canada Licensed.
Kit Manual: Download
The IDKmonitor® Infliximab Total ADA ELISA is intended for the determination of human antibodies against TNFα blocker infliximab (e.g. REMICADE®) in the presence of infliximab in EDTA plasma and serum. For research use only in the U.S. Health Canada Licensed.
This is the RUO version of Immundiagnostik part number K 9654.
|Dimensions||6.5 × 10 × 4.5 in|